Anja Daiminger

1.2k total citations
18 papers, 792 citations indexed

About

Anja Daiminger is a scholar working on Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anja Daiminger has authored 18 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 13 papers in Infectious Diseases and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anja Daiminger's work include Cytomegalovirus and herpesvirus research (18 papers), Parvovirus B19 Infection Studies (13 papers) and Herpesvirus Infections and Treatments (7 papers). Anja Daiminger is often cited by papers focused on Cytomegalovirus and herpesvirus research (18 papers), Parvovirus B19 Infection Studies (13 papers) and Herpesvirus Infections and Treatments (7 papers). Anja Daiminger collaborates with scholars based in Germany, France and Slovakia. Anja Daiminger's co-authors include Gisela Enders, Ursula Bäder, Martin Enders, Simone Exler, L Lindemann, Gunnar Schalasta, Kubilay Ertan, R. Bald, G H Enders and Anne Hilgendorff and has published in prestigious journals such as Journal of Clinical Microbiology, BJOG An International Journal of Obstetrics & Gynaecology and Clinical & Experimental Immunology.

In The Last Decade

Anja Daiminger

18 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anja Daiminger Germany 13 734 580 232 48 43 18 792
Ursula Bäder Germany 7 580 0.8× 463 0.8× 174 0.8× 35 0.7× 27 0.6× 10 630
Alessia Arossa Italy 12 742 1.0× 543 0.9× 193 0.8× 66 1.4× 67 1.6× 29 839
Tiffany Guilleminot France 11 524 0.7× 399 0.7× 171 0.7× 55 1.1× 42 1.0× 22 579
Simone Exler Slovakia 7 407 0.6× 315 0.5× 109 0.5× 30 0.6× 25 0.6× 11 439
April L. Palmer United States 10 688 0.9× 410 0.7× 217 0.9× 107 2.2× 33 0.8× 14 785
Valentina Venturi Italy 5 303 0.4× 156 0.3× 117 0.5× 23 0.5× 30 0.7× 6 358
Nadia Gussetti Italy 10 396 0.5× 177 0.3× 67 0.3× 34 0.7× 27 0.6× 16 424
Valentine Faure‐Bardon France 9 294 0.4× 236 0.4× 113 0.5× 52 1.1× 25 0.6× 20 385
Keren Shahar‐Nissan Israel 8 230 0.3× 211 0.4× 61 0.3× 20 0.4× 9 0.2× 14 341
Nazma Chowdhury United States 5 451 0.6× 249 0.4× 145 0.6× 67 1.4× 23 0.5× 5 498

Countries citing papers authored by Anja Daiminger

Since Specialization
Citations

This map shows the geographic impact of Anja Daiminger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Daiminger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Daiminger more than expected).

Fields of papers citing papers by Anja Daiminger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Daiminger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Daiminger. The network helps show where Anja Daiminger may publish in the future.

Co-authorship network of co-authors of Anja Daiminger

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Daiminger. A scholar is included among the top collaborators of Anja Daiminger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Daiminger. Anja Daiminger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Daiminger, Anja, et al.. (2024). Performance of eight commercial immunoassays for the detection of cytomegalovirus-specific IgM antibodies in pregnancy – no test fits all needs. Journal of Clinical Microbiology. 62(4). e0140723–e0140723. 2 indexed citations
2.
Exler, Simone, et al.. (2020). Low-level positive results in the Liaison CMV IgG II assay may misclassify pregnant woman as immune. Diagnostic Microbiology and Infectious Disease. 97(2). 115029–115029. 1 indexed citations
3.
Exler, Simone, et al.. (2019). Primary cytomegalovirus (CMV) infection in pregnancy: Diagnostic value of CMV PCR in saliva compared to urine at birth. Journal of Clinical Virology. 117. 33–36. 25 indexed citations
4.
Enders, Martin, Anja Daiminger, Simone Exler, & Gisela Enders. (2017). Amniocentesis for prenatal diagnosis of cytomegalovirus infection: challenging the 21 weeks' threshold. Prenatal Diagnosis. 37(9). 940–942. 16 indexed citations
5.
Enders, Martin, Anja Daiminger, Simone Exler, et al.. (2017). Prenatal diagnosis of congenital cytomegalovirus infection in 115 cases: a 5 years' single center experience. Prenatal Diagnosis. 37(4). 389–398. 50 indexed citations
6.
Enders, Gisela, Anja Daiminger, L Lindemann, et al.. (2012). Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996–2010. Medical Microbiology and Immunology. 201(3). 303–309. 70 indexed citations
7.
Enders, Gisela, et al.. (2012). The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. Journal of Clinical Virology. 56(2). 102–107. 33 indexed citations
8.
Enders, Gisela, Anja Daiminger, Ursula Bäder, Simone Exler, & Martin Enders. (2011). Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. Journal of Clinical Virology. 52(3). 244–246. 224 indexed citations
9.
Hilgendorff, Anne, et al.. (2009). Oral Valganciclovir Treatment in a CMV Congenital Infected Infant with Sensorineural Hearing Loss (SNHL) First Detected at 4 Months of Age. Klinische Pädiatrie. 221(7). 448–449. 12 indexed citations
10.
Daiminger, Anja, Ursula Bäder, & Gisela Enders. (2005). Pre‐ and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG An International Journal of Obstetrics & Gynaecology. 112(2). 166–172. 60 indexed citations
11.
Daiminger, Anja, et al.. (2005). Pre- and Periconceptional Primary Cytomegalovirus Infection: Risk of Vertical Transmission and Congenital Disease. Obstetrical & Gynecological Survey. 60(7). 420–422. 2 indexed citations
12.
Enders, Gisela, et al.. (2003). Zytomegalievirus- (CMV-) Durchseuchung und H�ufigkeit von CMV-Prim�rinfektionen bei schwangeren Frauen in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 46(5). 426–432. 11 indexed citations
13.
Enders, Gisela, Ursula Bäder, L Lindemann, Gunnar Schalasta, & Anja Daiminger. (2001). Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenatal Diagnosis. 21(5). 362–377. 198 indexed citations
14.
15.
16.
Daiminger, Anja, Ursula Bäder, & Gisela Enders. (1998). An enzyme linked immunoassay using recombinant antigens for differentiation of primary from secondary or past CMV infections in pregnancy. Journal of Clinical Virology. 11(2). 93–102. 17 indexed citations
17.
Daiminger, Anja, et al.. (1997). Diagnostic value of CD45RO expression on circulating T lymphocytes of fetuses and newborn infants with pre-, peri- or early post-natal infections. Clinical & Experimental Immunology. 107(2). 306–311. 22 indexed citations
18.
Daiminger, Anja, et al.. (1994). Detection of human cytomegalovirus in urine samples by cell culture, early antigen assay and polymerase chain reaction. Infection. 22(1). 24–28. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ursula Bäder Breakdown of academic impact, for papers by Alessia Arossa Breakdown of academic impact, for papers by Tiffany Guilleminot Breakdown of academic impact, for papers by Simone Exler Breakdown of academic impact, for papers by April L. Palmer Breakdown of academic impact, for papers by Valentina Venturi Breakdown of academic impact, for papers by Nadia Gussetti Breakdown of academic impact, for papers by Valentine Faure‐Bardon Breakdown of academic impact, for papers by Keren Shahar‐Nissan Breakdown of academic impact, for papers by Nazma Chowdhury
Rankless by CCL
2026